gip/glp-1 receptor agonist PDB-101: Molecule of the Month: GLP-1 Agonists The mechanism of GLP-1 and

Errafii et al

Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimers and Parkinsons disease therapeutics

New JAMA Study Links Wegovy to NAION A JAMA study published on July 3, 2024, on the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide found an increased risk of the condition in patients taking semaglutide compared to those taking non-GLP-1 RA medications

Table of Contents Introduction Expanded Indications for GLP-1 Receptor Agonists Emerging Therapies and Oral GLP-1 Options Cardiovascular and Renal Benefits Safety Considerations and Adverse Effects Conclusion FAQs Introduction Imagine a single class of medication that not only manages blood glucose but also offers cardiovascular and renal protection, aids in weight loss, and potentially reduces cancer risk

[DOI] [PubMed] [Google Scholar] 83.Ussher JR, Drucker DJ

Victoza is an injectable medication taken under the skin in the stomach area (abdomen), upper leg (thigh), or upper arm per the instructions of a healthcare provider